METHOD FOR TREATMENT OF A PATIENT SUFFERING FROM I OR II STAGE OF SYSTEMIC LUPUS ERYTHEMATOSUS

摘要

In various embodiments, the present invention relates to a method for the treatment of a patient suffering from I or II stage of systemic lupus erythematosus (SLE), comprising weekly administering in a dosage from about 1 to about 10 mg/kg during about 2 to about 52 weeks of a fusion molecule which comprises TACI extracellular domain or fragment thereof which binds BiyS, and a human immunoglobulin-constant domain.